Executive Order on Drug Pricing Could Have Positive Outcome: Allergan CEO
Friday, June 16, 2017 | Health Care
Allergan CEO Brent Saunders believes an executive order on drug pricing could have a positive impact and he believes his company is well-positioned to handle any changes. The Trump administration is preparing that executive order, which could be signed within weeks, Bloomberg reported Thursday, citing people close to the matter. The White House had no comment on the report.